![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_b2d54f313fd6fae3559ad99a1d264705.svg) | Imatinib | IC50 | 204.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_b2d54f313fd6fae3559ad99a1d264705.svg) | Imatinib | Ki | 14.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_986db0437f20070dfb14143a9f1b018d.svg) | Dasatinib | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_f59214b920b0faf58103b7de887f46c7.svg) | Nilotinib | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_4e9df3bd1ea0920231ce5d4b41666b94.svg) | Ponatinib | IC50 | 0.5 [1], 0.9 [2], 1.0 [3] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_b775a85698c0763438456cb9f84451b8.svg) | Methanesulfonic acid;N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-(piperazin-1-ylmethyl)benzamide | IC50 | 512.0 [1], 1558.0 [2], 2229.0 [3] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_11867fb79821176b92958b384e879689.svg) | CID 11478363 | IC50 | 1.25 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_13310ef99bc34e6207516fe68498dd1b.svg) | (2S)-2-Amino-2-methyl-4-[4-(heptyloxy)phenyl]-1-butanol | IC50 | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_0777dc765086e0fe44c81bec0cc1dba3.svg) | 4-Methyl-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 199.53 [1], 200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_e9382597e26c8d1359d4e3a95f9f85d6.svg) | 4-(2-Fluorobenzoyl)piperazino[4-[4-(3-fluorophenylamino)-6-pyrimidinyl]phenyl] ketone | IC50 | 17.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_cff96efedd42a47925e4c74806f38581.svg) | N-[3-[2-(4-Amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)ethynyl]phenyl]-3-(trifluoromethyl)benzamide | IC50 | 7.5 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_fbb6f13083e11fc5655f2848ec381d70.svg) | 4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[2-(2-pyrrolidin-1-ylpyrimidin-5-yl)ethynyl]benzamide | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_09f3f0270bc1267b182ef0a4c77c8588.svg) | 4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[2-(2-morpholin-4-ylpyrimidin-5-yl)ethynyl]benzamide | IC50 | 300.0 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_80b5c14d456c9eb78e427f13ac6e76a5.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(2,4-dichlorobenzoyl)piperazin-1-yl]methanone | IC50 | 14.0 [1], 450.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_f5812f07f2507152f1d1a258972cc02b.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(3-fluorobenzoyl)piperazin-1-yl]methanone | IC50 | 86.0 [1], 2070.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_636e963e9d9f1f02772cb9446a406b8b.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(3-methoxybenzoyl)piperazin-1-yl]methanone | IC50 | 49200.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_73f035850d32994df0603a9743d25c78.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(2-chlorobenzoyl)piperazin-1-yl]methanone | IC50 | 84.0 [1], 3410.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_443ed5570cc09c845ca411aa2ace45b6.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(2-bromobenzoyl)piperazin-1-yl]methanone | IC50 | 180.0 [1], 740.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_22b9e6c6c2f0d7f864d316e174a5a379.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-[3-(trifluoromethyl)benzoyl]piperazin-1-yl]methanone | IC50 | 2760.0 [1], 94570.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_7d5a59d336d44de2e55fd3df3f776a55.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(3,4-difluorobenzoyl)piperazin-1-yl]methanone | IC50 | 83520.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_3ca08a4cd748e6e8f00bc88ba9af949d.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(4-methoxybenzoyl)piperazin-1-yl]methanone | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_0ed53b6e77682b4105ee19c08a4aaa87.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(3-methylbenzoyl)piperazin-1-yl]methanone | IC50 | 2370.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_49859baeec85946bc97dd3749aa42e80.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(4-chlorobenzoyl)piperazin-1-yl]methanone | IC50 | 1890.0 [1], 65630.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_4a54cf15ef1dcfeb8ba0530d711213a1.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(2-methoxybenzoyl)piperazin-1-yl]methanone | IC50 | 22760.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_e2ac1cd9b5ee96ab386fb73e9c4ea18f.svg) | [4-(3-Amino-1H-indazol-4-yl)phenyl]-[4-(2-methylbenzoyl)piperazin-1-yl]methanone | IC50 | 8560.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_963e91c9b6faf05a5b37a7a98aadb11e.svg) | N-[2-[[4-(3-Amino-1H-indazol-4-yl)benzoyl]amino]ethyl]-3,4-difluorobenzamide | IC50 | 14320.0 [1], 75290.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_c45a131236a50bc5b5d58f9bd47c9b97.svg) | N-[2-[[4-(3-Amino-1H-indazol-4-yl)benzoyl]amino]ethyl]-2-bromobenzamide | IC50 | 31.0 [1], 1040.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_5e5ca74f142f24dcab1f9d28cf80e1cc.svg) | N-[2-[[4-(3-Amino-1H-indazol-4-yl)benzoyl]amino]ethyl]-2-methylbenzamide | IC50 | 18.0 [1], 28790.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_c907e089ccefc9704060bb6fd4cecbc8.svg) | N-[2-[[4-(3-Amino-1H-indazol-4-yl)benzoyl]amino]ethyl]-3-(trifluoromethyl)benzamide | IC50 | 450.0 [1], 56270.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_960cf39ca1948823ed582e35803e04db.svg) | N-[2-[[4-(3-Amino-1H-indazol-4-yl)benzoyl]amino]ethyl]-2-methoxybenzamide | IC50 | 250.0 [1], 100000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_72ee9e950c6f94df1ed0bbcb49162f83.svg) | 4-(3-Amino-1H-indazol-4-yl)-N-[2-[(4-methoxybenzoyl)amino]ethyl]benzamide | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_a27a808e822c8bd9c8ad692f8b2085a5.svg) | 3-[2-[3-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]isoquinolin-8-yl]ethynyl]-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 211.0 [1], 354.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_f126ca2cfc10ea1526b2f0231938785d.svg) | (E)-4-(2-(4-Bromobenzylthio)-3-(4-fluoro-3-nitrophenyl)acryloyl)benzoic acid | IC50 | 500.0 [1], 750.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_b4a851fc44492dd02e4ee2d94daab9b9.svg) | N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[[4-(trideuteriomethyl)piperazin-1-yl]methyl]benzamide | IC50 | 436.0 [1], 682.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_230be07d010b4d137320dbacfeeb5ff1.svg) | 3-[2-[2-(Cyclopropylamino)pyrimidin-5-yl]ethynyl]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 5.0 [1], 9.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_d922f550ba5c32eb542b6eca5e4631ba.svg) | 4-Methyl-3-[2-[2-(methylamino)pyrimidin-5-yl]ethynyl]-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 6.0 [1], 10.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_2c5991889fdcea3ec71bbc7e14a25aa6.svg) | 3-[2-[2-(Ethylamino)pyrimidin-5-yl]ethynyl]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 19.0 [1], 30.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_942baeeeeed1c89954a9ba8836771204.svg) | 4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[2-(2-piperidin-1-ylpyrimidin-5-yl)ethynyl]benzamide | IC50 | 904.0 [1], 1000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_2e939252fda861c4aaac8dcd02028e69.svg) | 3-[2-[2-(Cyclohexylamino)pyrimidin-5-yl]ethynyl]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 93.0 [1], 458.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_53c4f50219de514f9b75badb28d5357b.svg) | 3-[2-(2-Anilinopyrimidin-5-yl)ethynyl]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 161.0 [1], 238.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_ae7ca5ca5a0dae9fa248f7b4f7199fff.svg) | 3-[2-[2-(2-Hydroxyethylamino)pyrimidin-5-yl]ethynyl]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 18.0 [1], 19.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_dde38402e9401c880e3ce57567c2299f.svg) | 3-[2-[2-(Tert-butylamino)pyrimidin-5-yl]ethynyl]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 24.0 [1], 28.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_d0124185d63c7a20ae8be3baadd1b927.svg) | 4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[2-[2-(propan-2-ylamino)pyrimidin-5-yl]ethynyl]benzamide | IC50 | 125.0 [1], 187.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_c764885578756d3de4cad6b485c3f31d.svg) | 3-[2-(2-Aminopyrimidin-5-yl)ethynyl]-4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | IC50 | 7.0 [1], 8.0 [2] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 121.8 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_f51c285ab4c4b05b5a79103938f640a5.svg) | Resveratrol | IC50 | 28000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_b5f9e60dc2b2b7e76e07307c1d8f7888.svg) | Bosutinib | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_c404923147bfeecfccbf6d4c279dde7f.svg) | Pterostilbene | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_2060f6287083a28c9ead968a2460ede5.svg) | Tozasertib | IC50 | 50.12 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_4791112a6f6f5a8bf530b5de3f0bf307.svg) | (E)-3,5,4'-Trimethoxystilbene | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_90a328e1aa5bc573dfc7dfa3b8fd2306.svg) | 4-[[3-(Dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | IC50 | 3.98 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_33bc0283962e2a0c3729440054f4f20b.svg) | 6-(2,6-Dichlorophenyl)-8-methyl-2-((3-(methylthio)phenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_de4b64e4064f73bbde925d92efdb7237.svg) | 3-(6-((4-(Trifluoromethoxy)phenyl)amino)pyrimidin-4-yl)benzamide | IC50 | 267.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_5f14cab014f14c1e73f52633f2204187.svg) | Ast-487 | IC50 | 580.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_8b41edc658ff384bedf4ec89c5c66dfb.svg) | N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 398.11 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_ded02b65ef1463fae313a11911c40144.svg) | 1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 18.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_3dad2e0f3005c5fde874902c8035b6ae.svg) | 5-(6-Hydroxynaphthalen-2-yl)benzene-1,3-diol | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_6c38560dee3540f939fdaa0ff2c01d1d.svg) | N-(2-Chloro-6-methylphenyl)-2-[(2,6-dimethylpyrimidin-4-yl)amino]-1,3-thiazole-5-carboxamide | IC50 | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_55619603be8f6245d7236aed5771fc57.svg) | Flt-3 Inhibitor II | IC50 | 4200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_f9c70a6c5496c7752da294a5f6f9f6cc.svg) | 5-[4-(4-Hydroxyphenyl)phenyl]benzene-1,3-diol | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_d73af930e51a8589bebaeacbd9f91009.svg) | 3-Chloro-4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_c6a4dbbed41189365b44881da3e90691.svg) | N-[5-[(2S)-2-Methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide | IC50 | 25.12 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_9fd8475c9e7905fc09e61afb5781312b.svg) | 4-Amino-N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)benzamide | IC50 | 67608.3 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_ea6332263a004645f4bb1fc3c43d2f07.svg) | 7-[3-(Azetidin-1-yl)cyclobutyl]-5-(3-phenylmethoxyphenyl)pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_f9b97b2c9f478f100f04bd0e0f729874.svg) | 3-Fluoro-4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 63.1 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_68bfc7236c7d9864fc352488f22a30bd.svg) | 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | IC50 | 5.01 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_a9ab9fc62402963601c82ac3738f0779.svg) | N-[4-[4-(4-Methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]propanamide | IC50 | 602.56 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_0b4c7758e0dae8be20bde507a05eaaf8.svg) | 3-Iodo-4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_53152ec3f0b4cb551e7a43a91c600085.svg) | 3-Bromo-4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 7.08 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_1587894d875c8e86186ae3629b94454b.svg) | 5-[(E)-3,5-Dimethoxystyryl]phenol | IC50 | 26000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_d07c3e02f15efdbc5dadad9c74cb53e5.svg) | 4-(4-Methylpiperazin-1-yl)-N-[5-(2-thiophen-2-ylacetyl)-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]benzamide | IC50 | 64.57 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_6238525de36d6e163d562db0dd8c6cad.svg) | 4-[(4-Methyl-1-piperazinyl)methyl]-N-[3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_dd78d19a800ef44847dec4e766bbdb9f.svg) | 4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | IC50 | 3.98 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_1c3f448dcdf6985f3b83c6259ce95880.svg) | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | IC50 | 1513.56 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_b13f6f1984f9626c9cfd19fa5eb85808.svg) | 4-[[Hydroxymethyl(methyl)amino]diazenyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 3162.28 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_1d926f1b806ea891acaba54cc1836a82.svg) | 4-(Dimethylaminodiazenyl)-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 2187.76 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_ee6954d8746fbed71791328a2dd9a46e.svg) | 2-[(E)-2-(3,5-Dimethoxyphenyl)ethenyl]phenol | IC50 | 24000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_6ee55c3b02ef29fe6d26788e7145b8b3.svg) | 4-[[3-(Dimethylamino)azetidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | IC50 | 16.98 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_fa5e07784488382cd6f4b6c8e05eed3d.svg) | [3-(2-Imidazol-1-yl-ethoxy)-phenyl]-(4-pyridin-3-yl-pyrimidin-2-yl)-amine | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_1ab933be3af068e2d39845a83560bd49.svg) | N-[3-(4-Pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 398.11 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_5cab068ab186b59211a4342f191424aa.svg) | 1-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-3-(3-pyrrolidin-1-ylphenyl)urea | IC50 | 724.44 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_9fb99ec27a17e50a9811e615c6eec689.svg) | 6-(3,5-Dimethoxy-phenyl)-naphthalen-2-ol | IC50 | 42000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_95d999b48cbc5c0af8fd9da7fcad4812.svg) | 2-(3,5-Dimethoxy-phenyl)-6-methoxy-naphthalene | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_1c0672b167275420873e93bbcbc80ed2.svg) | (3-Imidazol-1-yl-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine | IC50 | 3311.31 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_a48938f0bcc140c4b47f4c8bb103a1f3.svg) | (3-Chloro-phenyl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine | IC50 | 1513.56 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_860b71db23f01c74cbea4c3987947ebb.svg) | N-(3-Methylphenyl)-4-pyridin-3-ylpyrimidin-2-amine | IC50 | 1819.7 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_808ce35a8d4888e1a05e5fb9422023c8.svg) | 4-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide | IC50 | 2700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_1ccd3b2521eb51116027a74a09cb2b7c.svg) | N-[4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-acetamide | IC50 | 5754.4 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_6e3eb1368c867f37a8c8486e838dff09.svg) | 4-Amino-N-[3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | IC50 | 9772.37 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_4f8c242c8835feec0fac43fc1f44f992.svg) | 4-[[2-Chloroethyl(methyl)amino]diazenyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | IC50 | 17378.01 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_d02ec66ca8c888229f19a57add51ccd7.svg) | N-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]piperidine-1-carboxamide | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_7550aa0d5d0ebb199551ff8af64d4127.svg) | 4-Methyl-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]piperazine-1-carboxamide | IC50 | 5011.87 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_581c9f6d4eb5ec3f8dfb07b582ae97c0.svg) | 1-[3-(Dimethylamino)phenyl]-3-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]urea | IC50 | 575.44 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_f0e229d3bff31d977e2dcd97296fcc5c.svg) | 1-[4-Methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-3-(2-pyrrolidin-1-ylethyl)urea | IC50 | 8912.51 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_97af85b09b9d86a6d01543d24c58411b.svg) | 1-[4-(Dimethylamino)phenyl]-3-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]urea | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_ee9c91b5ddb32bc485ca540a4763a8ee.svg) | 1-[3-(Diethylamino)phenyl]-3-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]urea | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_99986948f5936aceb647e2524645f7c8.svg) | 1-[4-(Diethylamino)phenyl]-3-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]urea | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_6d540c758796da56457b942bae6743e2.svg) | 4-[(E)-2-(3,5-Dimethoxy-phenyl)-vinyl]-2,6-dimethoxy-phenol | IC50 | 23000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_63b2c98b4335ee74c3592b4202de1a9b.svg) | 2-[3-(1,4-Diazepan-1-yl)anilino]-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidine-5-carbonitrile | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/bcr-abl-fusion-protein_0e57dd1eb58b575cc332fec3561866e1.svg) | N-(4-Pyridin-4-yl-pyrimidin-2-yl)-benzene-1,3-diamine | IC50 | 602.56 [1] |